Search Medical Condition
Please enter condition
Please choose location from dropdown

Hypertriglyceridemia Clinical Trials

A listing of Hypertriglyceridemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (51) clinical trials

A research study is evaluating an investigational medication for high triglycerides. This research study may be an option if you: • Are 18 years of age or older • Have been diagnosed with high triglyceride levels (>500mg/dL-<2000mg/dL) • Have normal kidney function • Have a Body Mass Index (BMI) less ...

Phase N/A

Do you have high triglycerides or hypertryglyceridemia?? Meridien Research needs volunteers for a clinical study of a new triglyceride-lowering medication.

Phase N/A

A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study With a 40-Week, Active-Controlled, Open-Label Extension to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting Triglyceride Levels =500 mg/dL and <2000 mg/dL and Mild or Moderate Renal Impairment

Phase N/A

After signing consent the subject will be taken off any other cholesterol medicine besides the statin, the statin therapy may be adjusted depending on their blood work results at Visit 1, if they are taking omega 3 dietary supplements they will be allowed to take only one capsule per day, ...

Phase

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Phase N/A

To access the efficacy, safety and tolerability of Gemcabene in subjects with severe hypertriglyceridemia.

Phase N/A

To evaluate the efficacy and safety of K-877 in subjects with fasting triglyceride levels ≥500mg/dL and <2000 mg/dL and normal renal function. Duration of study is 52 weeks on study drug.

Phase N/A

To determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting triglyceride (TG) levels in patients with fasting TG levels ≥500 mg/dL and ≤1500 mg/dL (≥5.7 mmol/L and ≤17.0 mmol/L) after 12 weeks of treatment.

Phase

The primary objective of the study is to determine whether pemafibrate administered twice daily will delay the time to first occurrence of any component of the clinical composite endpoint of: nonfatal Myocardial Infarction (MI) nonfatal ischemic stroke hospitalization for unstable angina requiring unplanned coronary revascularization; or Cardio Vascular (CV) death.

Phase N/A